Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,268 signal articles · 40 in last 24h · 115,355 total before filter · latest 2h ago
40last 24h
1786last 7d
298● bullish (7d)
169● bearish (7d)
205publishers
AllMacro317Earnings833M&A103Regulatory25Product16Analyst25
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Abbott Laboratories Q2 Earnings Call Highlights
MarketBeat30d agoneutral
Abbott Laboratories Q2 Earnings Call Highlights

Abbott Laboratories (NYSE:ABT) reported second-quarter 2026 comparable sales growth of 4.8% and adjusted earnings per share of $1.31, with Chairman and Chief Executive Officer Robert Ford saying results marked an acceleration from the prior two quarters. The company reaffirmed its full-year compara

UnitedHealth stock jumps on Q2 earnings, raises full-year outlook
Yahoo Finance Video30d agobullishVIDEO
UnitedHealth stock jumps on Q2 earnings, raises full-year outlook

Insurance giant UnitedHealth Group (UNH) is out with its second quarter earnings on Thursday, raising its full-year outlook alongside its reported $112 billion in quarterly revenue. The stock has jumped in Thursday trading. Mizuho Americas healthcare equity strategist Jared Holz takes a closer look at the insurer's stock performance and the role Medicare Advantage had in its figures.

TSMC Q2 profit beats estimates, ups spending as AI boom continues
Proactive30d agobullish
TSMC Q2 profit beats estimates, ups spending as AI boom continues

Taiwan Semiconductor Manufacturing Co (ADR) (NYSE:TSM) posted a 77% jump in second-quarter net profit and raised its capital spending forecast for the year, as the world's largest contract chipmaker rides sustained demand for AI processors. Net profit came in at $22.36 billion for the...

United Airlines shares fall as weak outlook overshadows Q2 earnings beat
Proactive30d agoneutral
United Airlines shares fall as weak outlook overshadows Q2 earnings beat

United Airlines Holdings Inc (NASDAQ:UAL, XETRA:UAL1) shares fell about 2% after the carrier issued third quarter earnings guidance below Wall Street expectations, despite reporting second quarter results that topped analyst estimates and raising its full-year adjusted earnings outlook. For...

Why Aehr Test Systems (AEHR) Is Up 29.3% After AI-Fueled 2027 Revenue Guidance And Record Backlog
Simply Wall St.30d agoneutral
Why Aehr Test Systems (AEHR) Is Up 29.3% After AI-Fueled 2027 Revenue Guidance And Record Backlog

Aehr Test Systems reported past fiscal fourth-quarter 2026 results with revenue of US$18.84 million and net income of US$1.39 million, while full-year 2026 sales were US$50.00 million with a net loss of US$7.13 million. The company entered fiscal 2027 with record quarterly bookings of US$60.70 million, an effective backlog above US$80 million, and issued revenue guidance of US$130 million to US$150 million driven by AI processors, silicon photonics, and power semiconductors. Next, we’ll...

Will Earnings Optimism and EV AI Momentum Change ON Semiconductor's (ON) Narrative?
Simply Wall St.30d agoneutral
Will Earnings Optimism and EV AI Momentum Change ON Semiconductor's (ON) Narrative?

In recent days, ON Semiconductor Corp. reported that analysts expect a meaningful uplift in upcoming quarterly earnings per share and revenue, even as the stock lagged a rising broader market. At the same time, Heartland Advisors highlighted ON Semiconductor’s strength in power management and image sensing for electric vehicles and AI datacenters, as well as its ongoing push toward higher-margin products and more efficient manufacturing. Next, we’ll explore how optimism around upcoming...

UnitedHealth Group Q2 Earnings Call Highlights
MarketBeat30d agoneutral
UnitedHealth Group Q2 Earnings Call Highlights

UnitedHealth Group (NYSE:UNH) reported sharply higher second-quarter 2026 earnings and raised its full-year outlook, citing improved performance in Medicare Advantage and Optum Health, while cautioning that commercial medical cost trends remain elevated and are delaying margin recovery in that busin